<i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological Studies

Leishmanicidal drugs have many side effects, and drug resistance to all of them has been documented. Therefore, the development of new drugs and the identification of novel therapeutic targets are urgently needed. <i>Leishmania mexicana</i> trypanothione reductase (LmTR), a NADPH-depende...

Full description

Bibliographic Details
Main Authors: Félix Matadamas-Martínez, Alicia Hernández-Campos, Alfredo Téllez-Valencia, Alejandra Vázquez-Raygoza, Sandra Comparán-Alarcón, Lilián Yépez-Mulia, Rafael Castillo
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/18/3216
id doaj-50f736332d504d28a4ccddbd55946140
record_format Article
spelling doaj-50f736332d504d28a4ccddbd559461402020-11-25T02:42:11ZengMDPI AGMolecules1420-30492019-09-012418321610.3390/molecules24183216molecules24183216<i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological StudiesFélix Matadamas-Martínez0Alicia Hernández-Campos1Alfredo Téllez-Valencia2Alejandra Vázquez-Raygoza3Sandra Comparán-Alarcón4Lilián Yépez-Mulia5Rafael Castillo6Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, MexicoDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, MexicoFacultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango Av. Universidad y Fanny Anitúa S/N, Durango 34000, MexicoFacultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango Av. Universidad y Fanny Anitúa S/N, Durango 34000, MexicoUnidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Unidad Médica de Alta Especialidad-Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, MexicoUnidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Unidad Médica de Alta Especialidad-Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, MexicoDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, MexicoLeishmanicidal drugs have many side effects, and drug resistance to all of them has been documented. Therefore, the development of new drugs and the identification of novel therapeutic targets are urgently needed. <i>Leishmania mexicana</i> trypanothione reductase (LmTR), a NADPH-dependent flavoprotein oxidoreductase important to thiol metabolism, is essential for parasite viability. Its absence in the mammalian host makes this enzyme an attractive target for the development of new anti-<i>Leishmania</i> drugs. Herein, a tridimensional model of LmTR was constructed and the molecular docking of 20 molecules from a ZINC database was performed. Five compounds (ZINC04684558, ZINC09642432, ZINC12151998, ZINC14970552, and ZINC11841871) were selected (docking scores &#8722;10.27 kcal/mol to &#8722;5.29 kcal/mol and structurally different) and evaluated against recombinant LmTR (rLmTR) and <i>L. mexicana</i> promastigote. Additionally, molecular dynamics simulation of LmTR-selected compound complexes was achieved. The five selected compounds inhibited rLmTR activity in the range of 32.9% to 40.1%. The binding of selected compounds to LmTR involving different hydrogen bonds with distinct residues of the molecule monomers A and B is described. Compound ZINC12151998 (docking score &#8722;10.27 kcal/mol) inhibited 32.9% the enzyme activity (100 &#181;M) and showed the highest leishmanicidal activity (IC<sub>50</sub> = 58 &#181;M) of all the selected compounds. It was more active than glucantime, and although its half-maximal cytotoxicity concentration (CC<sub>50</sub> = 53 &#181;M) was higher than that of the other four compounds, it was less cytotoxic than amphotericin B. Therefore, compound ZINC12151998 provides a promising starting point for a hit-to-lead process in our search for new anti-<i>Leishmania</i> drugs that are more potent and less cytotoxic.https://www.mdpi.com/1420-3049/24/18/3216trypanothione reductasemolecular dockingenzyme inhibitorsleishmanicidal activity
collection DOAJ
language English
format Article
sources DOAJ
author Félix Matadamas-Martínez
Alicia Hernández-Campos
Alfredo Téllez-Valencia
Alejandra Vázquez-Raygoza
Sandra Comparán-Alarcón
Lilián Yépez-Mulia
Rafael Castillo
spellingShingle Félix Matadamas-Martínez
Alicia Hernández-Campos
Alfredo Téllez-Valencia
Alejandra Vázquez-Raygoza
Sandra Comparán-Alarcón
Lilián Yépez-Mulia
Rafael Castillo
<i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological Studies
Molecules
trypanothione reductase
molecular docking
enzyme inhibitors
leishmanicidal activity
author_facet Félix Matadamas-Martínez
Alicia Hernández-Campos
Alfredo Téllez-Valencia
Alejandra Vázquez-Raygoza
Sandra Comparán-Alarcón
Lilián Yépez-Mulia
Rafael Castillo
author_sort Félix Matadamas-Martínez
title <i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological Studies
title_short <i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological Studies
title_full <i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological Studies
title_fullStr <i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological Studies
title_full_unstemmed <i>Leishmania mexicana</i> Trypanothione Reductase Inhibitors: Computational and Biological Studies
title_sort <i>leishmania mexicana</i> trypanothione reductase inhibitors: computational and biological studies
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2019-09-01
description Leishmanicidal drugs have many side effects, and drug resistance to all of them has been documented. Therefore, the development of new drugs and the identification of novel therapeutic targets are urgently needed. <i>Leishmania mexicana</i> trypanothione reductase (LmTR), a NADPH-dependent flavoprotein oxidoreductase important to thiol metabolism, is essential for parasite viability. Its absence in the mammalian host makes this enzyme an attractive target for the development of new anti-<i>Leishmania</i> drugs. Herein, a tridimensional model of LmTR was constructed and the molecular docking of 20 molecules from a ZINC database was performed. Five compounds (ZINC04684558, ZINC09642432, ZINC12151998, ZINC14970552, and ZINC11841871) were selected (docking scores &#8722;10.27 kcal/mol to &#8722;5.29 kcal/mol and structurally different) and evaluated against recombinant LmTR (rLmTR) and <i>L. mexicana</i> promastigote. Additionally, molecular dynamics simulation of LmTR-selected compound complexes was achieved. The five selected compounds inhibited rLmTR activity in the range of 32.9% to 40.1%. The binding of selected compounds to LmTR involving different hydrogen bonds with distinct residues of the molecule monomers A and B is described. Compound ZINC12151998 (docking score &#8722;10.27 kcal/mol) inhibited 32.9% the enzyme activity (100 &#181;M) and showed the highest leishmanicidal activity (IC<sub>50</sub> = 58 &#181;M) of all the selected compounds. It was more active than glucantime, and although its half-maximal cytotoxicity concentration (CC<sub>50</sub> = 53 &#181;M) was higher than that of the other four compounds, it was less cytotoxic than amphotericin B. Therefore, compound ZINC12151998 provides a promising starting point for a hit-to-lead process in our search for new anti-<i>Leishmania</i> drugs that are more potent and less cytotoxic.
topic trypanothione reductase
molecular docking
enzyme inhibitors
leishmanicidal activity
url https://www.mdpi.com/1420-3049/24/18/3216
work_keys_str_mv AT felixmatadamasmartinez ileishmaniamexicanaitrypanothionereductaseinhibitorscomputationalandbiologicalstudies
AT aliciahernandezcampos ileishmaniamexicanaitrypanothionereductaseinhibitorscomputationalandbiologicalstudies
AT alfredotellezvalencia ileishmaniamexicanaitrypanothionereductaseinhibitorscomputationalandbiologicalstudies
AT alejandravazquezraygoza ileishmaniamexicanaitrypanothionereductaseinhibitorscomputationalandbiologicalstudies
AT sandracomparanalarcon ileishmaniamexicanaitrypanothionereductaseinhibitorscomputationalandbiologicalstudies
AT lilianyepezmulia ileishmaniamexicanaitrypanothionereductaseinhibitorscomputationalandbiologicalstudies
AT rafaelcastillo ileishmaniamexicanaitrypanothionereductaseinhibitorscomputationalandbiologicalstudies
_version_ 1724774773623357440